Xiangyu Chen

4PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityNanotoxicology, health and safetyTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 04, 2026
Oncolytic virotherapy potentiates chemo-PD-1 immunotherapy by engaging chemo-resistant bystander CD8+ T cells.

Yang Yang, Junjian He, Texi Liang

|Sep 20, 2023
Dopamine Receptor 1 Impedes ILC2-Mediated Antitumor Immunity.

Xiangyang Wang, Xiangyu Chen, Jierong Chen

Pageof 1